Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433320 | PMC |
| http://dx.doi.org/10.1016/j.jdcr.2023.05.029 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Unilateral acneiform eruption in a patient with history of contralateral Horner syndrome.
JAAD Case Rep
August 2023
Department of Dermatology, Department of Medicine, Princess Norah Oncology Center, King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Becker's Birthmark: A Case Series of Pigmented Hairy Epidermal Naevus.
Indian J Dermatol
January 2023
From the Department of Dermatology, Venereology and Leprosy, SS Institute of Medical Sciences and Research Centre, Davanagere, Karnataka, India.
Article Synopsis
- Becker's naevus, also known as Becker's melanosis, is a type of skin growth characterized by brown pigmentation and excessive hair growth, primarily affecting young males after puberty.
- It has a prevalence of about 0.5% and typically appears as a noticeable, irregularly shaped dark spot on the upper body.
- Some cases can present with unusual features, leading to a condition called Becker's naevus syndrome, as evidenced by atypical presentations in two patients on their forearm and leg.
Becker's nevus syndrome: a case report.
J Med Case Rep
August 2021
Endocrine unit, Department of Paediatrics, University of Nigeria, Ituku Ozalla, Enugu, Nigeria.
Background: Becker's nevus syndrome is a syndrome characterized by the presence of a Becker's nevus with ipsilateral breast hypoplasia or hypoplastic defects of the muscle, skin, or skeleton. The nevus usually consists of a circumscribed, unilateral, irregularly shaped hyperpigmented macule, commonly occurring around the anterior upper trunk, with/without hypertrichosis and/or acneiform lesions. This rare syndrome has not been reported in our locality to the best of our knowledge.
View Article and Find Full Text PDF[Unilateral acneiform rash in facial palsy].
Ann Dermatol Venereol
November 2010
Hôpital Saint-Louis, AP-HP, Paris, France.
Background: Cetuximab is a chimeric monoclonal antibody selective for epidermal growth factor receptor (EGFR). It is increasingly used in epithelial cancer, often in combination with radiotherapy or chemotherapeutic agents, since it induces a broad range of cellular responses that enhance tumour sensitivity to these therapies. However, it can cause numerous adverse effects, the most common being acneiform eruption on the face and trunk, which is generally bilateral and symmetric.
View Article and Find Full Text PDFIt is the purpose of this review to extend our understanding of the fibroblast growth factor (FGF) receptor-2b-signaling network in the pathogenesis of acne. A new concept of the role of FGFR2b-signaling in dermal-epithelial interaction for skin appendage formation, pilosebaceous follicle homeostasis, comedogenesis, sebaceous gland proliferation and lipogenesis is presented. The FGFR2-gain-of-function mutations in Apert syndrome and unilateral acneiform nevus are most helpful model diseases pointing the way to androgen-dependent dermalepithelial FGFR2-signaling in acne.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!